☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Azurity
Azurity’s Konvomep Receives the US FDA’s Approval for the Treatment of Active Benign Gastric Ulcer
September 2, 2022
Azurity’s Zonisade Receives the US FDA’s Approval for Partial Seizures in Adults and Pediatric Patients with Epilepsy
July 18, 2022
Azurity’s Fleqsuvy Receives the US FDA’s Approval for the Treatment of Spasticity Associated with Multiple Sclerosis
February 7, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.